These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32534287)
1. Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains. Guz-Regner K; Komarnicka UK; Futoma-Kołoch B; Wernecki M; Cal M; Kozieł S; Ziółkowska A; Bugla-Płoskońska G J Inorg Biochem; 2020 Sep; 210():111124. PubMed ID: 32534287 [TBL] [Abstract][Full Text] [Related]
2. Cu Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049 [TBL] [Abstract][Full Text] [Related]
3. Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes. Kyzioł A; Cierniak A; Gubernator J; Markowski A; Jeżowska-Bojczuk M; Komarnicka UK Dalton Trans; 2018 Feb; 47(6):1981-1992. PubMed ID: 29345262 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and antibacterial studies of a copper(II) lomefloxacin ternary complex. Fernandes P; Sousa I; Cunha-Silva L; Ferreira M; de Castro B; Pereira EF; Feio MJ; Gameiro P J Inorg Biochem; 2014 Feb; 131():21-9. PubMed ID: 24239909 [TBL] [Abstract][Full Text] [Related]
5. Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode. Komarnicka UK; Starosta R; Płotek M; de Almeida RF; Jeżowska-Bojczuk M; Kyzioł A Dalton Trans; 2016 Mar; 45(12):5052-63. PubMed ID: 26674970 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of naphthyl derived bis-(3-hydroxy-4-pyridinonate) copper(II) complexes against multidrug-resistant bacteria. Leite A; Bessa LJ; Silva AMG; Gameiro P; de Castro B; Rangel M J Inorg Biochem; 2019 Aug; 197():110704. PubMed ID: 31078872 [TBL] [Abstract][Full Text] [Related]
8. Copper(i) complexes with phosphine derived from sparfloxacin. Part I - structures, spectroscopic properties and cytotoxicity. Komarnicka UK; Starosta R; Kyzioł A; Jeżowska-Bojczuk M Dalton Trans; 2015 Jul; 44(28):12688-99. PubMed ID: 26085118 [TBL] [Abstract][Full Text] [Related]
9. A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes. da Silva PB; Bonifácio BV; Frem RC; Godoy Netto AV; Mauro AE; Ferreira AM; Lopes Ede O; Raddi MS; Bauab TM; Pavan FR; Chorilli M Molecules; 2015 Dec; 20(12):22534-45. PubMed ID: 26694337 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterisation of phenanthroline-oxazine ligands and their Ag(I), Mn(II) and Cu(II) complexes and their evaluation as antibacterial agents. Ahmed M; Ward S; McCann M; Kavanagh K; Heaney F; Devereux M; Twamley B; Rooney D Biometals; 2022 Feb; 35(1):173-185. PubMed ID: 35037171 [TBL] [Abstract][Full Text] [Related]
13. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites. Lewis G; Juhasz A; Smith E Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580 [TBL] [Abstract][Full Text] [Related]
14. Zn(II), Ni(II), Cu(II) and Pb(II) complexes of tridentate asymmetrical Schiff base ligands: synthesis, characterization, properties and biological activity. Şahin M; Koçak N; Erdenay D; Arslan U Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():400-8. PubMed ID: 23274224 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens. Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276 [TBL] [Abstract][Full Text] [Related]
16. Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. Wang XD; Wei W; Wang PF; Tang YT; Deng RC; Li B; Zhou SS; Zhang JW; Zhang L; Xiao ZP; Ouyang H; Zhu HL Bioorg Med Chem; 2014 Jul; 22(14):3620-8. PubMed ID: 24882676 [TBL] [Abstract][Full Text] [Related]
17. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity. Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057 [TBL] [Abstract][Full Text] [Related]
18. Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action. Baecker D; Sesli Ö; Knabl L; Huber S; Orth-Höller D; Gust R Eur J Med Chem; 2021 Jan; 209():112907. PubMed ID: 33069056 [TBL] [Abstract][Full Text] [Related]
19. Conjugation of a new series of dithiocarbazate Schiff base Copper(II) complexes with vectors selected to enhance antibacterial activity. Low ML; Maigre L; Dorlet P; Guillot R; Pagès JM; Crouse KA; Policar C; Delsuc N Bioconjug Chem; 2014 Dec; 25(12):2269-84. PubMed ID: 25382115 [TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of meclofenamate metal complexes with Cd(II), Pb(II), Co(II), and Cu(II). Crystal structures of [Cd(C14H10NO2Cl2)2∙(CH3OH)]n and [Cu(C14H10NO2Cl2)2(C5H5N)2]. Palacios-Hernández T; Höpfl H; Sánchez-Salas JL; González-Vergara E; Pérez-Benítez A; Quiroz-Alfaro MA; Méndez-Rojas MA J Inorg Biochem; 2014 Oct; 139():85-92. PubMed ID: 25005722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]